The Hodgkin's cell in nodular sclerosis does not release interleukin-1

Area of Science:

• Oncology
• Cell Biology
• Immunology

Background:

• Hodgkin's disease is a cancer of the lymphatic system.
• Fibroblast hyperplasia is a common feature in nodular sclerosing Hodgkin's disease.
• The cellular origin of fibroblast-stimulating factors in this condition remains unclear.

Purpose of the Study:

• To investigate the production of transforming growth factor for fibroblasts and interleukin-1 by cell cultures from nodular sclerosing Hodgkin's disease.
• To determine if Hodgkin's cells or associated macrophages are responsible for fibroblast hyperplasia.

Main Methods:

• Cell cultures were established from lymph nodes of patients with nodular sclerosing Hodgkin's disease and healthy controls.
• Culture supernatants were analyzed for fibroblast transforming growth factor activity.
• Interleukin-1 activity was measured in conditioned media.
• Macrophage presence was confirmed using nonspecific esterase stains.

Main Results:

• Cell cultures from nodular sclerosing Hodgkin's disease produced a transforming growth factor for fibroblasts, unlike control cultures.
• Two Hodgkin's disease cultures produced measurable interleukin-1, with one showing persistent activity after macrophage depletion.
• Nonspecific esterase stains indicated the presence of macrophages in cultures with interleukin-1 activity.
• Alveolar macrophage cultures produced interleukin-1 but did not induce fibroblast colony formation.

Conclusions:

• Hodgkin's cells do not appear to produce measurable levels of interleukin-1.
• Interleukin-1 derived from Hodgkin's cells is unlikely to mediate the fibroblast hyperplasia observed in nodular sclerosing Hodgkin's disease.
• The fibroblast growth factor produced by these cultures may be responsible for the observed hyperplasia.